Physician profile
Sara Hyatt
NPI 1629505888
$1,203.89
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $280 · 2021: $90.54 · 2022: $611.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $285.73 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $150.72 | 2020 | |
| Allergan, INC. | $132.39 | 2021-2022 | |
| Abbvie INC. | $129.27 | 2022 | |
| Biotissue Holdings INC. | $103.33 | 2020-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $96.43 | 2019-2021 | |
| Alcon Vision LLC | $60.31 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $57.60 | 2019-2022 | |
| Shire North American Group INC | $56.84 | 2019 | |
| Visioneering Technologies, INC. | $37.17 | 2019 | |
| Horizon Therapeutics Plc | $30.88 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $22.42 | 2022 | |
| Aerie Pharmaceuticals, INC. | $21.40 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Hyatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.